Evidence map›Paper›PMID 40592976›Full record

ArticleScientific reports2025

Language models learn to represent antigenic properties of human influenza A(H3) virus.

Francesco Durazzi, Marion P G Koopmans, Ron A M Fouchier, Daniel Remondini

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Francesco DurazziDepartment of Physics and Astronomy, University of Bologna, 40127, Bologna, Italy.
Marion P G KoopmansDepartment of Viroscience, Erasmus Medical Centre, 3015 CN, Rotterdam, The Netherlands.
Ron A M FouchierDepartment of Viroscience, Erasmus Medical Centre, 3015 CN, Rotterdam, The Netherlands.
Daniel RemondiniDepartment of Physics and Astronomy, University of Bologna, 40127, Bologna, Italy. daniel.remondini@unibo.it.

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
European Commission 874735NIAID NIH HHS 75N93021C00014
6 · The paper itself

Abstract

Given that influenza vaccine effectiveness depends on a good antigenic match between the vaccine and circulating viruses, it is important to assess the antigenic properties of newly emerging variants continuously. With the increasing application of real-time pathogen genomic surveillance, a key question is if antigenic properties can reliably be predicted from influenza virus genomic information. Based on validated linked datasets of influenza virus genomic and wet lab experimental results, in silico models may be of use to learn to predict immune escape of variants of interest starting from the protein sequence only. In this study, we compared several machine-learning methods to reconstruct antigenic map coordinates for HA1 protein sequences of influenza A(H3N2) virus, to rank substitutions responsible for major antigenic changes, and to recognize variants with novel antigenic properties that may warrant future vaccine updates. Methods based on deep learning language models (BiLSTM and ProtBERT) and more classical approaches based solely on genetic distances and physicochemical properties of amino acid sequences had comparable performances over the coarser features of the map, but the first two performed better over fine-grained features like single amino acid-driven antigenic change and in silico deep mutational scanning experiments to rank the substitutions with the largest impact on antigenic properties. Given that the best performing model that produces protein embeddings is agnostic to the specific pathogen, the presented approach may be applicable to other pathogens.

Indexed as

Antigens, ViralHemagglutinin Glycoproteins, Influenza VirusInfluenza A Virus, H3N2 SubtypeInfluenza, HumanAntigenic VariationComputer SimulationDeep LearningHumansMachine LearningAntigens, ViralHemagglutinin Glycoproteins, Influenza Virus

Identifiers

PMID40592976
PMCPMC12219074

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.